<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Alterations of brain tissue structural complexity and disorder in Alzheimer's disease (AD): Fractal, multifractal, fractal transformation, and disorder strength analyses - Health AI Hub</title>
    <meta name="description" content="This paper introduces a multiparametric framework combining fractal, multifractal, a novel fractal functional distribution analysis, and inverse participation r">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Alterations of brain tissue structural complexity and disorder in Alzheimer's disease (AD): Fractal, multifractal, fractal transformation, and disorder strength analyses</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.07061v1" target="_blank">2512.07061v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-08
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Santanu Maity, Mousa Alrubayan, Mohammad Moshahid Khan, Prabhakar Pradhan
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> physics.med-ph, nlin.CD, physics.bio-ph, physics.optics
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.07061v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.07061v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces a multiparametric framework combining fractal, multifractal, a novel fractal functional distribution analysis, and inverse participation ratio (IPR) analysis to quantify subtle microstructural alterations in Alzheimer's disease (AD) brain tissue. The framework effectively identifies threshold-dependent fractal signatures and demonstrates increased structural disorder with disease progression, providing a robust method for early diagnosis and improved pathological assessment.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Early and sensitive detection of microstructural changes in Alzheimer's disease is critical for timely intervention and effective disease management. This research provides advanced quantitative tools that could lead to more accurate early diagnoses and improved monitoring of AD progression, surpassing the limitations of current diagnostic methods.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The novel fractal and multifractal parameters, along with the derived Gaussian distribution parameters, developed in this paper could serve as robust, quantitative features for machine learning and AI algorithms. These features could be used to train AI models for automated early diagnosis of Alzheimer's disease, classification of disease stages, and objective pathological assessment from microscopy or advanced imaging data, thereby enhancing diagnostic accuracy and efficiency in clinical settings.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Developed a multiparametric framework leveraging fractal and multifractal analysis, and their distributions, to quantify microstructural deterioration in AD brain tissue.</li>
                    
                    <li>Introduced a novel 'fractal functional distribution method' that transforms fractal distributions into a statistically interpretable Gaussian form, capable of distinguishing control from diseased tissues.</li>
                    
                    <li>Identified pronounced threshold-dependent behavior of fractal and multifractal parameters, which serve as quantitative signatures reflecting the intrinsic sparsity and heterogeneous intensity landscape of AD tissue.</li>
                    
                    <li>Utilized inverse participation ratio (IPR) analysis, an established light localization technique, to quantify structural disorder and complexity in AD brain tissue.</li>
                    
                    <li>IPR-based analysis demonstrated that increasing IPR pixel size directly correlates with an elevation of structural alterations, indicative of disease progression.</li>
                    
                    <li>The identified threshold-sensitive signatures and distribution parameters offer potential biomarkers for early pathological transitions and quantitative stage detection in AD.</li>
                    
                    <li>The integrated analyses establish a robust, multi-scale quantitative framework for detecting subtle microstructural changes, addressing limitations of conventional imaging and histopathology.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study applied a multiparametric framework to human brain tissue samples. The key analytical methods included:
1.  **Fractal and Multifractal Analysis**: Quantifying the scaling properties and heterogeneity of brain tissue structures.
2.  **Fractal Functional Distribution Method**: A novel technique to transform fractal distributions into Gaussian forms for easier statistical interpretation and differentiation of tissue states.
3.  **Inverse Participation Ratio (IPR) Analysis**: An established light localization technique utilized to assess structural disorder and complexity, examining how IPR pixel size correlates with observed alterations.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The study found that fractal and multifractal parameters exhibit pronounced threshold-dependent behavior, providing unique signatures indicative of AD progression. The novel fractal functional distribution method yields statistically interpretable parameters capable of differentiating healthy and AD-affected tissues. Furthermore, IPR-based analysis demonstrated a clear elevation of structural alterations with disease progression, especially highlighted by increasing IPR pixel size, collectively establishing a robust, multi-scale quantitative framework for detecting microstructural alterations in AD.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This research holds significant potential for clinical impact by enabling earlier and more precise diagnosis of Alzheimer's disease through novel, sensitive biomarkers derived from brain tissue microstructural complexity. It offers a quantitative approach for disease staging and monitoring progression, potentially allowing for more timely therapeutic interventions and personalized treatment strategies beyond what conventional imaging and histopathology can provide.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>Limitations of this specific study are not explicitly detailed in the abstract. However, the work aims to overcome the inherent lack of sensitivity in detecting subtle early-stage changes in AD using conventional imaging and histopathology.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>While not explicitly stated as 'future work', the paper implies that these integrative analyses provide a promising foundation for future efforts. This includes the clinical validation and translation of these methods into diagnostic workflows, aiming to establish them as robust biomarkers for early AD diagnosis, quantitative stage detection, and improved pathological assessment in practical clinical settings.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Neurology</span>
                    
                    <span class="tag">Neuropathology</span>
                    
                    <span class="tag">Diagnostic Imaging</span>
                    
                    <span class="tag">Geriatrics</span>
                    
                    <span class="tag">Neurodegenerative Diseases</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Alzheimer's disease</span>
                    
                    <span class="tag tag-keyword">fractal analysis</span>
                    
                    <span class="tag tag-keyword">multifractal analysis</span>
                    
                    <span class="tag tag-keyword">inverse participation ratio (IPR)</span>
                    
                    <span class="tag tag-keyword">microstructural alterations</span>
                    
                    <span class="tag tag-keyword">early diagnosis</span>
                    
                    <span class="tag tag-keyword">biomarkers</span>
                    
                    <span class="tag tag-keyword">brain tissue complexity</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Alzheimer's disease (AD) is characterized by progressive microstructural deterioration in brain tissue, yet conventional imaging and histopathology often lack the sensitivity needed to detect subtle early-stage changes. Here, we present a multiparametric framework combining fractal and multifractal analysis and their distributions to quantify structural alterations in human brain tissue affected by AD. Moreover, from the fractal and multifractal formalism, we introduced an innovative fractal functional distribution method, a novel technique that transforms fractal distribution into a Gaussian form. Statistically, these distribution parameters are easy to interpret and can distinguish between control and diseased tissues. Across samples, we identify pronounced threshold-dependent behavior of fractal and multifractal parameters, reflecting the intrinsic sparsity and heterogeneous intensity landscape of brain tissue. These threshold-sensitive signatures provide a framework for quantitative stage detection and may serve as biomarkers for early pathological transitions. In addition, we studied structural disorder and complexity using our established light localization technique, inverse participation ratio (IPR) analysis. IPR-based analysis demonstrates that increasing IPR pixel size highlights the elevation of structural alterations with disease progression. Together, these integrative analyses establish a robust, multi-scale quantitative framework for detecting microstructural alterations in AD, providing a promising foundation for early diagnosis and improved pathological assessment.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>22 pages, 8 figures</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>